Emily B Schroeder1, Stan Xu2, Glenn K Goodrich2, Gregory A Nichols3, Patrick J O'Connor4, John F Steiner5. 1. Institute for Health Research, Kaiser Permanente Colorado, Denver, CO; Department of Medicine, University of Colorado Denver, Aurora, CO. Electronic address: Emily.x.schroeder@kp.org. 2. Institute for Health Research, Kaiser Permanente Colorado, Denver, CO. 3. Center for Health Research, Kaiser Permanente Northwest, Portland, OR. 4. HealthPartners Research Institute and HealthPartners Center for Chronic Care Innovation, Minneapolis, MN. 5. Institute for Health Research, Kaiser Permanente Colorado, Denver, CO; Department of Medicine, University of Colorado Denver, Aurora, CO.
Abstract
AIMS: To develop and externally validate a prediction model for the 6-month risk of a severe hypoglycemic event among individuals with pharmacologically treated diabetes. METHODS: The development cohort consisted of 31,674 Kaiser Permanente Colorado members with pharmacologically treated diabetes (2007-2015). The validation cohorts consisted of 38,764 Kaiser Permanente Northwest members and 12,035 HealthPartners members. Variables were chosen that would be available in electronic health records. We developed 16-variable and 6-variable models, using a Cox counting model process that allows for the inclusion of multiple 6-month observation periods per person. RESULTS: Across the three cohorts, there were 850,992 6-month observation periods, and 10,448 periods with at least one severe hypoglycemic event. The six-variable model contained age, diabetes type, HgbA1c, eGFR, history of a hypoglycemic event in the prior year, and insulin use. Both prediction models performed well, with good calibration and c-statistics of 0.84 and 0.81 for the 16-variable and 6-variable models, respectively. In the external validation cohorts, the c-statistics were 0.80-0.84. CONCLUSIONS: We developed and validated two prediction models for predicting the 6-month risk of hypoglycemia. The 16-variable model had slightly better performance than the 6-variable model, but in some practice settings, use of the simpler model may be preferred.
AIMS: To develop and externally validate a prediction model for the 6-month risk of a severe hypoglycemic event among individuals with pharmacologically treated diabetes. METHODS: The development cohort consisted of 31,674 Kaiser Permanente Colorado members with pharmacologically treated diabetes (2007-2015). The validation cohorts consisted of 38,764 Kaiser Permanente Northwest members and 12,035 HealthPartners members. Variables were chosen that would be available in electronic health records. We developed 16-variable and 6-variable models, using a Cox counting model process that allows for the inclusion of multiple 6-month observation periods per person. RESULTS: Across the three cohorts, there were 850,992 6-month observation periods, and 10,448 periods with at least one severe hypoglycemic event. The six-variable model contained age, diabetes type, HgbA1c, eGFR, history of a hypoglycemic event in the prior year, and insulin use. Both prediction models performed well, with good calibration and c-statistics of 0.84 and 0.81 for the 16-variable and 6-variable models, respectively. In the external validation cohorts, the c-statistics were 0.80-0.84. CONCLUSIONS: We developed and validated two prediction models for predicting the 6-month risk of hypoglycemia. The 16-variable model had slightly better performance than the 6-variable model, but in some practice settings, use of the simpler model may be preferred.
Authors: Ram D Pathak; Emily B Schroeder; Elizabeth R Seaquist; Chan Zeng; Jennifer Elston Lafata; Abraham Thomas; Jay Desai; Beth Waitzfelder; Gregory A Nichols; Jean M Lawrence; Andrew J Karter; John F Steiner; Jodi Segal; Patrick J O'Connor Journal: Diabetes Care Date: 2015-12-17 Impact factor: 19.112
Authors: B Cariou; P Fontaine; E Eschwege; M Lièvre; D Gouet; D Huet; S Madani; S Lavigne; B Charbonnel Journal: Diabetes Metab Date: 2014-11-24 Impact factor: 6.041
Authors: Gregory A Nichols; Emily B Schroeder; Andrew J Karter; Edward W Gregg; Jay Desai; Jean M Lawrence; Patrick J O'Connor; Stanley Xu; Katherine M Newton; Marsha A Raebel; Ram D Pathak; Beth Waitzfelder; Jodi Segal; Jennifer Elston Lafata; Melissa G Butler; H Lester Kirchner; Abraham Thomas; John F Steiner Journal: Am J Epidemiol Date: 2014-12-16 Impact factor: 4.897
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Gregory A Nichols; Jay Desai; Jennifer Elston Lafata; Jean M Lawrence; Patrick J O'Connor; Ram D Pathak; Marsha A Raebel; Robert J Reid; Joseph V Selby; Barbara G Silverman; John F Steiner; W F Stewart; Suma Vupputuri; Beth Waitzfelder Journal: Prev Chronic Dis Date: 2012-06-07 Impact factor: 2.830
Authors: Elizabeth R Seaquist; John Anderson; Belinda Childs; Philip Cryer; Samuel Dagogo-Jack; Lisa Fish; Simon R Heller; Henry Rodriguez; James Rosenzweig; Robert Vigersky Journal: Diabetes Care Date: 2013-04-15 Impact factor: 19.112
Authors: Sisi Ma; Pamela J Schreiner; Elizabeth R Seaquist; Mehmet Ugurbil; Rachel Zmora; Lisa S Chow Journal: J Biomed Inform Date: 2020-01-28 Impact factor: 6.317
Authors: René Rodríguez-Gutiérrez; Alejandro Salcido-Montenegro; José Gerardo González-González; Rozalina G McCoy Journal: BMJ Open Diabetes Res Care Date: 2021-04
Authors: Rozalina G McCoy; Rodolfo J Galindo; Kavya Sindhu Swarna; Holly K Van Houten; Patrick J O'Connor; Guillermo E Umpierrez; Nilay D Shah Journal: JAMA Netw Open Date: 2021-09-01
Authors: Simon Heller; Ildiko Lingvay; Steven P Marso; Athena Philis-Tsimikas; Thomas R Pieber; Neil R Poulter; Richard E Pratley; Elise Hachmann-Nielsen; Kajsa Kvist; Martin Lange; Alan C Moses; Marie Trock Andresen; John B Buse Journal: Diabetes Obes Metab Date: 2020-12 Impact factor: 6.577